ISpecimen Inc.: reports special meeting vote results

What happened

• ISpecimen Inc. reported in a Current Report on Form 8-K that it held a special meeting of stockholders on Oct 9, 2026. As of the close of business on Aug 12, 2026, there were 2,518,590 shares of common stock outstanding and entitled to vote. A total of 1,287,547 shares were present in person or represented by proxy, approximately 51.1% of the shares outstanding, constituting a quorum. The filing reported final voting results for Proposal Nos. 1, 3, 4 and 5, and that Proposal No. 2 (reverse stock split) was adjourned to Oct 30, 2026 at 10:00 a.m. Eastern to be held virtually.

Key details

• Proposal No. 1 (approval pursuant to Nasdaq Listing Rule 5635(d) for pre-funded warrants): FOR 779,705; AGAINST 33,092; ABSTAIN 160; BROKER NON-VOTE 474,590. Proposal 1 was approved.
• Proposal No. 3 (approval pursuant to Nasdaq Listing Rule 5635(d) for future convertible financing transactions): FOR 782,722; AGAINST 30,099; ABSTAIN 136; BROKER NON-VOTE 474,590. Proposal 3 was approved.
• Proposal No. 4 (approval of asset acquisition pursuant to the Asset Purchase Agreement dated Sep 4, 2026 with Foldlab AI Ltd.): FOR 791,600; AGAINST 21,269; ABSTAIN 88; BROKER NON-VOTE 474,590. Proposal 4 was approved.
• Proposal No. 5 (approval of adjournment to solicit additional proxies): FOR 1,150,689; AGAINST 112,799; ABSTAIN 24,059; BROKER NON-VOTE 0. Proposal 5 was approved. Proposal No. 2 (reverse stock split amendment to effect a reverse split in a range of 1-for-10 to 1-for-100) was adjourned with respect to voting to the Adjourned Meeting on Oct 30, 2026; proxies previously submitted for Proposal No. 2 remain valid and the record date for the Adjourned Meeting remains Aug 12, 2026. The company filed its definitive proxy statement with the SEC on Sep 14, 2026.

Why it may matter

• This Form 8-K reports Item 5.07, submission of matters to a vote of security holders, covering the Oct 9, 2026 special meeting results, approvals of Proposals 1, 3, 4 and 5, and the adjournment of Proposal 2 to Oct 30, 2026. The filing does not show why the insider traded or why the company acted.